To successfully complete this program, the PGY2 resident must complete all required, elective, and longitudinal rotations. The resident must complete a research project, present the project at an approved venue, and submit a manuscript suitable for publication. The resident will present, at minimum, one pharmacotherapy conference (Res Rounds) lecture, one didactic lecture and one journal club. Additional requirements include completion of a medication use evaluation (MUE), publication of one article in the RXPress newsletter, weekly prior authorization drug requests, precepting pharmacy residents and/or students, required staffing and completion of an electronic residency portfolio. The resident must also be in compliance with institutional and departmental policies.

• Orientation (1-4 weeks depending on incoming experience and skill)

• Longitudinal Clinical Rotations (6 months)
  • Anticoagulation (2-4 week focused block*, then 2 half days/week)
  • Primary Care I/II/Community Based Outpatient Clinic (CBOC) (2-4 week focused block*, then 2.5-3 days/week)
  • Elective (2-4 week focused block*, then 1 half day/week)
  • Practice Management/Administration (1-2 half days/week)

Duration of focused block dependent on incoming experience and skill

• Infectious Disease/HIV (4 weeks)
• Primary Care – Community Based Outpatient Clinic (CBOC) (4 weeks)
• Women’s Health (4 weeks)

• Academia
• Cardiology
• Emergency Medicine
• Hematology/Oncology
• Home Based Primary Care
• Internal Medicine
• Mental Health
• Pharmacy Informatics
• Spinal Cord Injury

• ER-Fast Track/Staffing (year-long)
• Practice Management/Administration (year-long)
• Prior Authorization Drug Requests (year-long)
• Research (year-long)
• Electives (3-6 month block)
  • Cardiology
  • Home Based Primary Care
  • Infectious Disease/HIV
  • Mental Health

The PGY2 resident will gain many diverse teaching experiences throughout the year, including precepting PGY1 residents and students. In addition, the resident will be expected to provide in-service presentations to medical and pharmacy staff and a minimum of one therapeutics lecture at Texas Southern University College of Pharmacy and Health Sciences or the University of Houston College of Pharmacy. The resident is highly encouraged to apply to become a Texas State Board of Pharmacy licensed preceptor. If not previously obtained during PGY1 residency training, the resident will also have the opportunity to complete a teaching certificate program offered by the University of Houston College of Pharmacy.

The resident is highly encouraged to attend two conferences per residency year:

• American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting
• Texas Society of Health-System Pharmacists (TSHP) Alcalde Southwest Leadership Conference or another ambulatory care focused conference as approved by Pharmacy Leadership

• Yearly salary of $51,995 (2022-2023)
• 11 paid holidays
• 13 days accrued annual and 13 days accrued sick leave
• Federal Employee Health Benefits (FEHB)

• U.S. citizen
• Licensed pharmacist in any state within the U.S.
• Graduate of an ACPE-accredited Doctor of Pharmacy program
• Completion of an ASHP-accredited PGY1 residency prior to the start of this program
• Participate in an interview

• Letter of Intent
• Curriculum vitae
• Three letters of recommendation
• Official pharmacy school transcript(s) sent to PhORCAS
• VA Application form VHA-10-2850d  ***Upload to supplemental application on PhORCAS***

Applications for this program will be accepted through the PhORCAS online application system. The application deadline is January 2nd of every year. The National Matching Service Code is 674665.